For the quarter ending 2026-03-31, DXCM has $6,633,300K in assets. $3,676,400K in debts. $1,118,200K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 1,118,200 | 917,700 | 1,835,700 | 1,159,000 |
| Debt securities, available-for-sale | - | - | - | 1,769,300 |
| Marketable equity securities | - | - | - | 1,000 |
| Short-term marketable securities | 1,297,000 | 1,081,000 | 1,486,400 | 1,770,300 |
| Accounts receivable, net | 1,088,600 | 1,216,100 | 1,109,600 | 1,348,800 |
| Inventory | 693,600 | 629,100 | 604,100 | 570,700 |
| Prepaid and other current assets | 134,300 | 189,400 | 183,700 | 181,400 |
| Total current assets | 4,331,700 | 4,033,300 | 5,219,500 | 5,030,200 |
| Property and equipment, net | 1,559,700 | 1,559,900 | 1,471,300 | 1,457,300 |
| Operating lease right-of-use assets | 73,100 | 77,400 | 54,000 | 56,400 |
| Goodwill | 24,200 | 24,200 | 24,100 | 24,100 |
| Intangibles, net | 62,600 | 70,800 | 79,000 | 87,200 |
| Deferred tax assets | 296,100 | 295,600 | 375,600 | 496,300 |
| Other assets | 285,900 | 278,700 | 276,500 | 175,500 |
| Total assets | 6,633,300 | 6,339,900 | 7,500,000 | 7,327,000 |
| Accounts payable and accrued liabilities | 2,073,900 | 1,944,000 | 1,932,400 | 1,943,800 |
| Accrued payroll and related expenses | 121,800 | 169,200 | 170,200 | 129,300 |
| Current portion of long-term senior convertible notes | - | 0 | 1,206,900 | 1,206,100 |
| Short-term operating lease liabilities | 20,500 | 21,600 | 23,600 | 23,400 |
| Deferred revenue | - | - | 2,900 | 6,100 |
| Other current liabilities | 7,600 | 7,700 | - | - |
| Total current liabilities | 2,223,800 | 2,142,500 | 3,336,000 | 3,308,700 |
| Long-term senior convertible notes | 1,241,800 | 1,240,900 | 1,239,900 | 1,238,900 |
| Long-term operating lease liabilities | 69,000 | 73,400 | 50,600 | 54,700 |
| Other long-term liabilities | 141,800 | 137,100 | 147,400 | 151,600 |
| Total liabilities | 3,676,400 | 3,593,900 | 4,773,900 | 4,753,900 |
| Common stock, 0.001 par value, 800.0 million shares authorized 412.3 million and 385.9 million shares issued and outstanding, respectively, at march31, 2026 and 410.7 million and 384.8 million shares issued and outstanding, respectively, at december31, 2025 | 400 | 400 | 400 | - |
| Additional paid-in capital | 2,337,500 | 2,281,500 | 2,246,500 | 2,187,500 |
| Accumulated other comprehensive income | 106,200 | 115,000 | 81,500 | 83,600 |
| Retained earnings | 2,633,400 | 2,433,900 | 2,166,600 | 1,882,800 |
| Treasury stock, at cost 26.4 million shares at march31, 2026 and 25.9 million shares at december31, 2025 | 2,120,600 | 2,084,800 | 1,768,900 | 1,581,200 |
| Total stockholders equity | 2,956,900 | 2,746,000 | 2,726,100 | 2,573,100 |
| Total liabilities and stockholders equity | 6,633,300 | 6,339,900 | 7,500,000 | 7,327,000 |
DEXCOM INC (DXCM)
DEXCOM INC (DXCM)